BMI increase during early childhood in boys with cystic fibrosis and early adrenarche

Gizem Tamer,Hubertus Gerardus Maria Arets,Cornelis Kors van der Ent,Hanneke Margo van Santen,Hetty Jacoba van der Kamp
DOI: https://doi.org/10.1002/ppul.26861
IF: 4.0899
2024-01-27
Pediatric Pulmonology
Abstract:Background Increase in body mass index (BMI) in early childhood (1−6 years) was found to be a contributing factor for impaired final height in boys with Cystic Fibrosis (CF). Early adrenarche (before age 9 years in boys) may contribute to an impaired final height by triggering an early acceleration of bone age resulting in a compromised growth spurt during puberty. We aimed to analyze the timing of adrenarche in boys with CF and to associate BMI increase in early childhood to timing of adrenarche. Methods Boys with CF, aged 8−9 years, visiting the CF expertize center Utrecht were included. Since 2018, anthropomorphic, pubertal and endocrine data were collected. Early adrenarche in boys was defined as a dehydroepiandrosterone sulfate (DHEAS) ≥ 1 μmol/L before the age of 9 years. Results Thirteen boys (mean age 8.55 ± 0.27 years) were enrolled. The median (IQR) DHEAS‐level was 1.3 μmol/L (0.71−2.40). Eight boys (61.5%) had an early rise in DHEAS‐levels ≥ 1 μmol/L. Mean increase in BMI Z‐score between 1 and 6 years of age (ΔBMI1−6) was −0.07 ± 0.86. A significant correlation was found between ΔBMI1−6 and DHEAS‐levels at the age of 8−9 years (r = 0.624, p = 0.040). In five boys with early rise in DHEAS, accelerated bone age was found (average 1.55 ± 0.96 years). Conclusion In this small cohort, 61.5% of boys with CF between 8 and 9 years had an early rise of DHEAS, which was correlated to ΔBMI1−6 between 1 and 6 years. Early adrenarche may be caused by ΔBMI1−6.
pediatrics,respiratory system
What problem does this paper attempt to address?